Committed to better health for individuals, Takeda Pharmaceuticals North America, Inc. (TPNA) develops and markets innovative pharmaceutical treatments.
In addition to the success of our on-the-market products, Takeda invests in an active R&D pipeline in an effort to bring new treatments to patients in need.
Click here for more R&D pipeline information.
ACTOS®, ACTOplus met®, ACTOplus met® XR, and duetact® are registered trademarks of Takeda Pharmaceutical Company Limited and used under license by Takeda Pharmaceuticals America, Inc.
AMITIZA® is a registered trademark of Sucampo Pharmaceuticals, Inc.
DEXILANT and KAPIDEX are trademarks of Takeda Pharmaceuticals North America, Inc. and used under license by Takeda Pharmaceuticals America, Inc.
PREVACID® and PREVPAC® are registered trademarks of Takeda Pharmaceuticals North America, Inc. and used under license by Takeda Pharmaceuticals America, Inc.
ROZEREM® is a registered trademark of Takeda Pharmaceutical Company Limited and used under license by Takeda Pharmaceuticals America, Inc.
ULORIC® is a registered trademark of Teijin Pharma Limited and used under license by Takeda Pharmaceuticals America, Inc.
Please click here to view Takeda’s authorized wholesalers and distributors.